Identifying the Impact of Chlamydia trachomatis Screening and Treatment on Mother-to-Child Transmission, and Respiratory Neonatal Outcomes in Mexico.

MLA

Arteaga-Troncoso, Gabriel, et al. “Identifying the Impact of Chlamydia Trachomatis Screening and Treatment on Mother-to-Child Transmission, and Respiratory Neonatal Outcomes in Mexico.” Pathogens, vol. 13, no. 10, Oct. 2024, p. 843. EBSCOhost, https://doi.org/10.3390/pathogens13100843.

APA

Arteaga-Troncoso, G., López-Hurtado, M., Yescas-Buendía, G., de Haro-Cruz, M. J., Arteaga-Martínez, I. A., Villagrana-Zesati, J. R., & Guerra-Infante, F. M. (2024). Identifying the Impact of Chlamydia trachomatis Screening and Treatment on Mother-to-Child Transmission, and Respiratory Neonatal Outcomes in Mexico. Pathogens, 13(10), 843. https://doi.org/10.3390/pathogens13100843

Chicago

Arteaga-Troncoso, Gabriel, Marcela López-Hurtado, Gabino Yescas-Buendía, María J. de Haro-Cruz, Iván Alejandro Arteaga-Martínez, Jesús Roberto Villagrana-Zesati, and Fernando M. Guerra-Infante. 2024. “Identifying the Impact of Chlamydia Trachomatis Screening and Treatment on Mother-to-Child Transmission, and Respiratory Neonatal Outcomes in Mexico.” Pathogens 13 (10): 843. doi:10.3390/pathogens13100843.